Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DCF Valuation
Base-case fair value
€5.92
Intrinsic €7.90 · 25% MOS
Base-case summary
Our base-case DCF for Geratherm Medical AG (GME.XETR) projects 10 years of free cash flow growth at 20.0% for years 1–5 and 10.0% for years 6–10, anchored to 98.3% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from €712000 in trailing free cash flow, this produces an intrinsic value of €7.90 per share. A 25% safety margin gives a fair value of €5.92.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
€712000
Cash & equivalents
€9M
Total debt
€2M
Shares outstanding
5M